TWST (STOCKS)
Twist Bioscience Corporation Common Stock
$123.395800
-1.814200 (-1.45%)
Prev close: $125.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Emily Marine Leproust
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,219.18M
- Employees
- 923
- P/E (TTM)
- -56.34
- P/B (TTM)
- 17.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $431.80M |
| Benefits Costs and Expenses | $567.65M |
| Cost Of Revenue | $207.41M |
| Costs And Expenses | $576.78M |
| Gross Profit | $224.39M |
| Operating Expenses | $369.36M |
| Selling, General, and Administrative Expenses | $290.29M |
| Research and Development | $71.86M |
| Operating Income/Loss | -$144.98M |
| Income/Loss From Continuing Operations After Tax | -$136.72M |
| Income/Loss From Continuing Operations Before Tax | -$135.85M |
| Income Tax Expense/Benefit | $864.00K |
| Net Income/Loss | -$136.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$136.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$136.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.22 |
| Diluted Earnings Per Share | -$2.22 |
| Basic Average Shares | 123,998,000 |
| Diluted Average Shares | 123,998,000 |
| Assets | $672.44M |
| Current Assets | $321.30M |
| Inventory | $35.16M |
| Prepaid Expenses | $9.96M |
| Other Current Assets | $276.17M |
| Noncurrent Assets | $351.14M |
| Fixed Assets | $111.89M |
| Other Non-current Assets | $239.25M |
| Liabilities | $226.70M |
| Current Liabilities | $120.26M |
| Accounts Payable | $17.04M |
| Wages | $34.88M |
| Other Current Liabilities | $68.33M |
| Noncurrent Liabilities | $106.44M |
| Equity | $445.74M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $445.74M |
| Liabilities And Equity | $672.44M |
| Net Cash Flow From Operating Activities | -$53.07M |
| Net Cash Flow From Operating Activities, Continuing | -$53.07M |
| Net Cash Flow From Investing Activities | -$45.24M |
| Net Cash Flow From Investing Activities, Continuing | -$45.24M |
| Net Cash Flow From Financing Activities | $13.80M |
| Net Cash Flow From Financing Activities, Continuing | $13.80M |
| Exchange Gains/Losses | $176.00K |
| Net Cash Flow | -$84.34M |
| Net Cash Flow, Continuing | -$84.52M |
| Comprehensive Income/Loss | -$136.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$136.51M |
| Other Comprehensive Income/Loss | $209.00K |